2). In an RCT,
Kianifard et al361 analyzed the benefits of adding SEPS to
saphenofemoral ligation and stripping of the GSV in patients
with class C2 disease. The study allocated 38 to the SEPS
group and 34 to the no-SEPS group. The two groups were
similar with respect to pain, mobility, varicose vein recurrence,
and QOL scores during the 1-year